Determinants of Bladder Cancer Recurrence Study (The DETER Study)
Active, not recruiting
- Conditions
- Bladder Cancer
- Registration Number
- NCT02400944
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- Patients ≥18 years old AND
- Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)
Exclusion Criteria
- Patients are ineligible for the study if they have/had:
- Histologically-confirmed NMIBC diagnosed >36 months prior to enrollment
- Cystectomy prior to enrollment
- Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures
- Non English-speaking
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recurrence 1 year will be defined as the presence of pathologically-confirmed NMIBC lesion \>8 weeks after diagnosis
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
Memorial Sloan Kettering Commack
🇺🇸Commack, New York, United States
Memorial Sloan Kettering Westchester
🇺🇸Harrison, New York, United States
Memorial Sloan Kettering Cancer Center🇺🇸New York, New York, United States